Clinical Trial Update: Zilver Flex Post-Market Study in Japan [NA]

View source ↗

Summary

The post-market study of Zilver Flex in Japan for Peripheral Arterial Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Zilver Flex

Snippet

Sponsor: Cook Group Incorporated | Conditions: Peripheral Arterial Disease (PAD) | NA | Status: COMPLETED